What requirements do clinical trials have to meet? How does a product become reimbursable? How does the conformity assessment procedure work? Representatives from the Federal Institute for Drugs and Medical Devices (BfArM) and the Federal Joint Committee (G-BA), with regard to Medicinal Products and Medical Devices (ZLG) will be available for one-on-one discussions about the path of an innovation from research to supply.
One-on-one discussions can be booked via www.medizintechnologie.de or directy at hall 10.0/booth 309.